These findings establish astrocytic PERK deficiency as a sufficient driver of synaptic and network dysfunction underlying depressive phenotypes and highlight astrocyte-directed TSP1 augmentation as a potential therapeutic strategy for MDD. The gene discussed is THBS1; the disease is major depressive disorder.